Clinical Trials
Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced initial data from its Phase 2 study showing that a single 50...
Clinical Trials
Vaxart Oral COVID-19 Vaccine Phase I Study Suggests Broad...
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced at Vaxart’s key opinion leader...
Clinical Trials
Kintor Pharmaceuticals Announces Successful Proxalutamide COVID-19 Phase III Clinical...
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the phase III clinical trial of proxalutamide for the...
Clinical Trials
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading...
Thermo Fisher Scientific Inc., the world leader in serving science, and PPD, Inc., a leading global provider of clinical research services to the pharma and...
Clinical Trials
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine...
Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced clinical and supply updates on its COVID-19 Vaccine program. New results from...
Clinical Trials
Catalent Biologics Completes Madison Facility Expansion to Double Clinical...
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced...
Clinical Trials
Lilly and Incyte announce results from the Phase 3...
Eli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily plus standard of care (SoC)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.